The spreadsheet was part of a detailed analyst's report. The spreadsheet supported the SPEC BUY recommendation at the time.
My point is that biotechs are historically all about "hope and hype." Why would ADO be any different? Sure, it "might" be successful but then again it might all end in tears as it did for many BTA investors who paid over $9 per share.
- Forums
- ASX - By Stock
- ADO
- haspete chart please
haspete chart please, page-291
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
-0.001(4.35%) |
Mkt cap ! $54.77M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.1¢ | $2.746K | 127.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 76017 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 373226 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 76017 | 0.022 |
12 | 2019127 | 0.021 |
11 | 1081001 | 0.020 |
7 | 1049486 | 0.019 |
6 | 2172779 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 373226 | 3 |
0.024 | 716664 | 6 |
0.025 | 1050470 | 10 |
0.026 | 291415 | 3 |
0.027 | 250000 | 1 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |